PFPRX
Price
$57.41
Change
-$0.29 (-0.50%)
Updated
Jun 2 closing price
Net Assets
817.35M
PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
Interact to see
Advertisement

PFPRX vs PMBCX

Header iconPFPRX vs PMBCX Comparison
Open Charts PFPRX vs PMBCXBanner chart's image
PFPRX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
PFPRX vs. PMBCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PFPRX is a Buy and PMBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. PFPRX (817M). PFPRX (0.00) and PMBCX (0.00) have matching dividends . PFPRX was incepted earlier than PMBCX: PFPRX (11 years) vs PMBCX (19 years). PMBCX (1.71) is less costly to investors than PFPRX (0.70). PFPRX is a more actively managed with annual turnover of: 61.51 vs. PMBCX (13.70). PMBCX has a lower initial minimum investment than PFPRX: PMBCX (1000) vs PFPRX (100000). PFPRX annual gain was more profitable for investors over the last year : 2.34 vs. PMBCX (-15.11). PFPRX return over 5 years is better than : -6.28 vs. PMBCX (-9.16).
PFPRXPMBCXPFPRX / PMBCX
Total Expense Ratio0.681.7140%
Annual Report Gross Expense Ratio0.701.7141%
Fund Existence11 years19 years-
Gain YTD6.040-7.252-83%
Front LoadN/AN/A-
Min. Initial Investment100000100010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets817M24.6B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year2.34-15.11-15%
Returns for 3 years19.459.97195%
Returns for 5 years-6.28-9.1669%
Returns for 10 years50.9353.2096%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity